Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-26-000013·Dolby Laboratories, Inc.
Schedule 13G ownership disclosure
Dolby Laboratories Inc
Class A Common Stock · CUSIP: 25659T107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 6,192,241 · Class: 10.2%
- Atlanta Capital Management Company, LLC
Shares: 5,226,244 · Class: 8.6%
- Eaton Vance Atlanta Capital SMID-Cap Fund
Shares: 3,965,479 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-26-000013
- Form type
- SCHEDULE 13G/A
- Filer
- Dolby Laboratories, Inc.
- CIK
- CIK 1308547
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership